-
Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitis
Verstockt, B., Alsoud, D., van Oostrom, J., Verstockt, S., Smith, J., Stylli, J., Singh, S., van Gennep, S., Rahimian, P., Sabino, J., Ferrante, M., Kelman, A., Singh, S., D'Haens, G. & Vermeire, S., 1 May 2025, In: J. Crohn's Colitis. 19, 5, jjaf063.Research output: Contribution to journal › Article* › Academic › peer-review
-
A Narrative Systematic Review and Categorisation of Outcomes in Inflammatory Bowel Disease to Inform a Core Outcome Set for Real-world Evidence
Wong, C., van Oostrom, J., Bossuyt, P., Pittet, V., Hanzel, J., Samaan, M., Tripathi, M., Czuber-Dochan, W., Burisch, J., Leone, S., Saldaña, R., Baert, F., Kopylov, U., Jaghult, S., Adamina, M., Gecse, K. & Arebi, N., 1 Nov 2022, In: Journal of Crohn's & colitis. 16, 10, p. 1511-1522 12 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study
European COMBIO study group, Dec 2021, In: United European gastroenterology journal. 9, 10, p. 1136-1147 12 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
